Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 5/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.36 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.36 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.36 |
| ▸ | ACACB | O00763 | 3/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12134134 | 0.91 | ADORA3 (0.53) | ADORA3PPARAELANEESR1ESR2 | |
| SCHEMBL16160655 | 0.86 | ADORA3 (0.43) | ADORA3PPARA | |
| SCHEMBL15521085 | 0.86 | ADORA3 (0.57) | ADORA3PPARAELANEESR1ESR2 | |
| SCHEMBL14643611 | 0.85 | ADORA3 (0.60) | ADORA3PPARAELANEESR1ESR2 | |
| SCHEMBL13313103 | 0.84 | ADORA3 (0.56) | ADORA3ELANEESR1ESR2SLC6A4 | |
| SCHEMBL10122316 | 0.83 | ADORA3 (0.62) | ADORA3PPARAELANEESR1ESR2 | |
| SCHEMBL21164190 | 0.83 | PSMB1 (0.48) | ADORA3PPARAESR1ESR2PSMB1 | |
| SCHEMBL26722810 | 0.82 | ADORA3 (0.45) | ADORA3PPARAELANEESR1ESR2 | |
| SCHEMBL10084007 | 0.82 | ADORA3 (0.60) | ADORA3PPARAELANEESR1ESR2 | |
| SCHEMBL18056748 | 0.82 | ADORA3 (0.60) | ADORA3PPARAELANEESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8105739-B2 | Multilayer; conductive support and photosensitive layer containing charge generating compound containing triple bond and hydroxy group | FUJI XEROX CO., LTD. (JP) | 2012-01-31 | — | — | US | disclosed |
| US-8021813-B2 | Electrostatic-image-developing toner, method of producing the same, electrostatic image developer, image forming method and image forming apparatus | FUJI XEROX CO., LTD. (JP) | 2011-09-20 | — | — | US | disclosed |
| US-20090274972-A1 | ELECTROSTATIC-IMAGE-DEVELOPING TONER, METHOD OF PRODUCING THE SAME, ELECTROSTATIC IMAGE DEVELOPER, IMAGE FORMING METHOD AND IMAGE FORMING APPARATUS | FUJI XEROX CO., LTD. (JP) | 2009-11-05 | — | — | US | disclosed |
| US-20080220356-A1 | Electrophotographic photoreceptor, process cartridge and image-forming apparatus | FUJI XEROX CO., LTD. (JP) | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274972-A1 | ELECTROSTATIC-IMAGE-DEVELOPING TONER, METHOD OF PRODUCING THE SAME, ELECTROSTATIC IMAGE DEVELOPER, IMAGE FORMING METHOD AND IMAGE FORMING APPARATUS | PPIP5K2, PHOSPHO1, CASR | ADORA3 2414/4885PPARA 2517/4885ELANE 3259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.